Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes

BACKGROUND: Diabetes mellitus is a risk for increased incidence of adverse clinical events after percutaneous coronary intervention. However, the difference in the incidence of adverse clinical events according to stent type in patients with diabetes remains to be elucidated. In the present study, w...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cardiovasc Diabetol
Auteurs principaux: Kakizaki, Ryota, Minami, Yoshiyasu, Katamine, Masahiro, Katsura, Aritomo, Muramatsu, Yusuke, Hashimoto, Takuya, Meguro, Kentaro, Shimohama, Takao, Ako, Junya
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Original Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7531093/
https://ncbi.nlm.nih.gov/pubmed/33004019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-01145-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires